Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
|
March 21, 2000
Reducing adverse effects of inhaled fenoterol through optimization of the aerosol formulation
P Zanen, J W Lammers
European Journal of Clinical Pharmacology
|
January 1, 1995
Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence
P Zanen, J W Lammers
International Journal of Clinical Practice. Supplement
|
November 11, 2005
Could interchangeable use of dry powder inhalers affect patients?
D Price, M Summers, P Zanen
Arzneimittel-Forschung
|
October 1, 1988
Bronchospasmolytic effects of salbutamol as powder inhalation in patients with reversible bronchial obstruction
M Deenstra, P Zanen, C F Gusdorf
European Journal of Clinical Pharmacology
|
May 20, 1998
The efficacy of a low-dose, monodisperse parasympathicolytic aerosol compared with a standard aerosol from a metered-dose inhaler
P Zanen, L T Go, J W Lammers
Thorax
|
October 1, 1996
Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction
P Zanen, L T Go, J W Lammers
International Journal of Clinical Practice. Supplement
|
November 11, 2005
Can patients use all dry powder inhalers equally well?
P Gustafsson, A Taylor, P Zanen, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
January 1, 1991
The effect of inhalation flow on the performance of a dry powder inhalation system
H van der Kolk, P Zanen, E Tushuizen, et al.
Respiratory Medicine
|
December 13, 2002
Reduction of variability of exhaled nitric oxide in healthy volunteers
I van der Lee, J M M van den Bosch, P Zanen
International Journal of Pharmaceutics
|
September 25, 2002
Metal versus plastic spacers: an in vitro and in vivo comparison
R Janssen, M Weda, M B Ekkelenkamp, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
|
March 21, 2000
Reducing adverse effects of inhaled fenoterol through optimization of the aerosol formulation
P Zanen, J W Lammers
European Journal of Clinical Pharmacology
|
January 1, 1995
Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence
P Zanen, J W Lammers
International Journal of Clinical Practice. Supplement
|
November 11, 2005
Could interchangeable use of dry powder inhalers affect patients?
D Price, M Summers, P Zanen
Arzneimittel-Forschung
|
October 1, 1988
Bronchospasmolytic effects of salbutamol as powder inhalation in patients with reversible bronchial obstruction
M Deenstra, P Zanen, C F Gusdorf
European Journal of Clinical Pharmacology
|
May 20, 1998
The efficacy of a low-dose, monodisperse parasympathicolytic aerosol compared with a standard aerosol from a metered-dose inhaler
P Zanen, L T Go, J W Lammers
Thorax
|
October 1, 1996
Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction
P Zanen, L T Go, J W Lammers
International Journal of Clinical Practice. Supplement
|
November 11, 2005
Can patients use all dry powder inhalers equally well?
P Gustafsson, A Taylor, P Zanen, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
January 1, 1991
The effect of inhalation flow on the performance of a dry powder inhalation system
H van der Kolk, P Zanen, E Tushuizen, et al.
Respiratory Medicine
|
December 13, 2002
Reduction of variability of exhaled nitric oxide in healthy volunteers
I van der Lee, J M M van den Bosch, P Zanen
International Journal of Pharmaceutics
|
September 25, 2002
Metal versus plastic spacers: an in vitro and in vivo comparison
R Janssen, M Weda, M B Ekkelenkamp, et al.
Page
of 5